SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
23 hedge funds and large institutions have $94.4M invested in scPharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 23 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
+23
Holders Change %
–
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$41.2M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$34.5M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$3.68M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.42M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.18M |
Top Sellers
No sellers this quarter
